502 lines
22 KiB
HTML
502 lines
22 KiB
HTML
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
|
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
|
<head>
|
|
<meta http-equiv="X-UA-Compatible" content="IE=8;" />
|
|
<meta name="twitter:card" content="summary_large_image">
|
|
<meta name="twitter:site" content="@NLM_NIH">
|
|
<meta name="twitter:title" content="MEDLINE Data Changes — 2013: Revised Entry Combinations Table. NLM Technical Bulletin. 2012 Nov–Dec">
|
|
<meta name="twitter:description" content=" The NLM Technical Bulletin is your source to stay informed about NLM products and services.">
|
|
<meta name="twitter:image" content="https://www.nlm.nih.gov/pubs/techbull/images/nlm_tech_bulletin_graphic_twitter.jpg">
|
|
<meta property="og:url" content="https://www.nlm.nih.gov/pubs/techbull/tb.html" />
|
|
<meta property="og:type" content="article" />
|
|
<meta property="og:title" content="MEDLINE Data Changes — 2013: Revised Entry Combinations Table. NLM Technical Bulletin. 2012 Nov–Dec" />
|
|
<meta property="og:description" content="The NLM Technical Bulletin is your source to stay informed about NLM products and services." />
|
|
<meta property="og:image" content="https://www.nlm.nih.gov/pubs/techbull/images/nlm_tech_bulletin_graphic_facebook.jpg" />
|
|
<link type="text/css" href="/pubs/techbull/styles/reset.css" rel="stylesheet" />
|
|
|
|
<link type="text/css" href="/pubs/techbull/styles/technicalBulletin.css" rel="stylesheet" />
|
|
<!--Call jQuery-->
|
|
<script src="//assets.nlm.nih.gov/jquery/jquery-latest.min.js"></script>
|
|
<script src="//assets.nlm.nih.gov/jquery/jquery-migrate-latest.min.js"></script>
|
|
<script src="/pubs/techbull/scripts/techbull.js" type="text/javascript" language="javascript"></script>
|
|
<!--[if lte IE 8]>
|
|
<script type="text/javascript" src="/scripts/PIE.js"></script>
|
|
<![endif]-->
|
|
<link type="text/css" href="/pubs/techbull/styles/print.css" rel="stylesheet" media="print"/>
|
|
<title>MEDLINE Data Changes — 2013: Revised Entry Combinations Table. NLM Technical Bulletin. 2012 Nov–Dec</title>
|
|
<link rel="schema.DC" href="http://purl.org/dc/elements/1.1/" title="The Dublin Core metadata Element Set" />
|
|
<meta name="DC.Title" content="MEDLINE Data Changes — 2013: Revised Entry Combinations Table" />
|
|
|
|
<meta name="DC.Publisher" content="U.S. National Library of Medicine" />
|
|
<meta name="DC.Date.Issued" content="2012-11-13" />
|
|
<meta name="DC.Date.Modified" content="2013-07-18" />
|
|
<meta name="NLMDC.Date.LastReviewed" content="2013-07-18" />
|
|
<meta name="NLM.Contact.Email" content="nlmtechbull@mail.nlm.nih.gov" />
|
|
<meta name="DC.Type" content="Newsletters" />
|
|
<meta name="NLM.Permanence.Level" content="Permanent: Stable Content" />
|
|
<meta name="NLM.Permanence.Guarantor" content="U.S. National Library of Medicine" />
|
|
<meta name="DC.Rights" content="Public Domain" />
|
|
<meta name="DC.Language" content="eng" />
|
|
|
|
|
|
<meta name="DC.Subject.Keyword" content="Update" />
|
|
<meta name="DC.Subject.Keyword" content="Entry Combination" />
|
|
<meta name="DC.Subject.Keyword" content="MEDLINE" />
|
|
<meta name="DC.Subject.Keyword" content="Medical Subject Headings" />
|
|
<meta name="DC.Subject.Keyword" content="Subheading" />
|
|
|
|
<!-- Google Tag Manager -->
|
|
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-MT6MLL');</script>
|
|
<!-- End Google Tag Manager -->
|
|
</head>
|
|
<body>
|
|
<!-- Google Tag Manager -->
|
|
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-MT6MLL" height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript>
|
|
<!-- End Google Tag Manager -->
|
|
<div class="skipnavigation"><a title="Skip the navigation on this page" href="#skipnav" class="skipnavigation">Skip Navigation Bar</a></div>
|
|
|
|
<div>
|
|
|
|
<div class="header">
|
|
<img src="/pubs/techbull/images/tb_logo_113.jpg" alt="National Library of Medicine Technical Bulletin" title="National Library of Medicine Technical Bulletin" /><img src="/pubs/techbull/images/nlm_masthead_113.jpg" alt="National Library of Medicine Technical Bulletin" title="National Library of Medicine Technical Bulletin" usemap="#nlm_masthead_113" />
|
|
</div>
|
|
|
|
<div class="search_box">
|
|
<form method="get" action="//vsearch.nlm.nih.gov/vivisimo/cgi-bin/query-meta" target="_self" name="searchForm" class="searchForm">
|
|
<label class="displaynone" for="search">Search</label>
|
|
<input name="query" id="search" type="text" class="search-input inactive" size="50" onfocus="this.value=''" value="Search here for NLM Technical Bulletin articles" aria-label="Search NLM Technical Bulletin">
|
|
<input type="hidden" name="v:project" value="technical-bulletin">
|
|
</form>
|
|
</div>
|
|
|
|
</div>
|
|
|
|
<div id="nav">
|
|
<!--Open drop-->
|
|
<ul class="topnav">
|
|
<li class="currentissue"><a href="//www.nlm.nih.gov/pubs/techbull/current_issue.html">Current Issue</a> <img class="separator" src="/pubs/techbull/images/whitelinetransparentbackground.gif " alt=""/></li>
|
|
<li class="archive"><a href="//www.nlm.nih.gov/pubs/techbull/back_issues.html">Previous Issues</a> <img class="separator" src="/pubs/techbull/images/whitelinetransparentbackground.gif " alt=""/></li>
|
|
<li class="about"><a href="//www.nlm.nih.gov/pubs/techbull/about.html">About</a> <img class="separator" src="/pubs/techbull/images/whitelinetransparentbackground.gif " alt=""/></li>
|
|
<li class="staycurrent"><a href="//www.nlm.nih.gov/pubs/techbull/stay_current.html">Stay Current <img class="emaillogo" src="/pubs/techbull/images/email_20px.gif" alt="E-Mail Sign Up" style="margin-top: -4px;"/> <img class="rsslogo" src="/pubs/techbull/images/rss_20px.gif" alt="RSS Feed" style="margin-top: -4px;"/></a></li>
|
|
</ul>
|
|
<!--Close drop-->
|
|
</div>
|
|
<div class="body">
|
|
<a id="skipnav" name="skipnav"></a>
|
|
<div class="syndicate">
|
|
<p class="tableOfContents"><strong>Table of Contents: <a href="/pubs/techbull/nd12/nd12_issue_cover.html">2012 NOVEMBER–DECEMBER No. 389</a></strong></p>
|
|
<p class="prevnext"><span class="buttons">
|
|
<span class="previous"><a href="nd12_cataloging_news_2013.html">Previous</a></span> <span class="next"><a href="nd12_medline_data_changes_2013.html">Next</a></span>
|
|
|
|
</span></p>
|
|
<hr class="hr1" />
|
|
<h1 class="articleH1">MEDLINE Data Changes — 2013: Revised Entry Combinations Table</h1>
|
|
<p class="tbyearmonth">Revised Entry Combinations Table — 2013. NLM Tech Bull. 2012 Nov-Dec;(389):e4b.</p>
|
|
<div class="articleactions">2012 November 30 <span class="status">[posted]</span>
|
|
|
|
|
|
|
|
</div>
|
|
<div class="articleParagraph">
|
|
|
|
<a href="/pubs/techbull/nd12/nd12_medline_data_changes_2013.html#ec">Return to <em>MEDLINE Data Changes — 2013</em> article</a>.
|
|
|
|
<br />
|
|
<br />
|
|
|
|
<table width="750" cellspacing="0" cellpadding="4" summary="Previous MeSH Heading/Subheading
|
|
(Entry Combination) and the Replaced-by Heading for 2013.">
|
|
|
|
<thead>
|
|
<tr>
|
|
<th id="a1" width="425" align="left"><strong>Previous MeSH Heading/Subheading<br />
|
|
(Entry Combination)</strong></th>
|
|
<th id="a2" width="325" align="left"><strong>Replaced-by Heading for 2013<br />
|
|
</strong></th>
|
|
</tr>
|
|
</thead>
|
|
|
|
<tbody>
|
|
|
|
<tr><td headers="a1"> 4-Aminobenzoic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> para-Aminobenzoates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Acetic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Acetates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Acid Sensing Ion Channels/agonists</td>
|
|
<td headers="a2"> Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Acid Sensing Ion Channels/antagonists & inhibitors</td>
|
|
<td headers="a2"> Acid Sensing Ion Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> Benzoic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Benzoates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Butyric Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Butyrates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspase 1/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspase 2/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspase 3/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspase 6/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspase 7/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspase 8/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspase 9/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspase 10/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspase 12/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspase 14/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspases/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspases, Effector/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Caspases, Initiator/antagonists & inhibitors</td>
|
|
<td headers="a2"> Caspase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Collagenases/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Degenerin Sodium Channels/agonists</td>
|
|
<td headers="a2"> Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Degenerin Sodium Channels/antagonists & inhibitors</td>
|
|
<td headers="a2"> Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> Dichloroacetic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Chloroacetates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Epithelial Sodium Channels/agonists</td>
|
|
<td headers="a2"> Epithelial Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Epithelial Sodium Channels/antagonists & inhibitors</td>
|
|
<td headers="a2"> Epithelial Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> Glucuronic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Glucuronates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Hearing Impaired Persons/education</td>
|
|
<td headers="a2"> Education of Hearing Disabled</td> </tr>
|
|
|
|
<tr><td headers="a1"> Iodoacetic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Iodoacetates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 1/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 2/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 3/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 7/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 8/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 9/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 10/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 11/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 12/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 13/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 14/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 15/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 16/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 17/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinase 20/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinases/antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Matrix Metalloproteinases, Membrane-Associated/<br />
|
|
antagonists & inhibitors</td>
|
|
<td headers="a2"> Matrix Metalloproteinase Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Mesenchymal Stromal Cells/transplantation</td>
|
|
<td headers="a2"> Mesenchymal Stem Cell Transplantation</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.1 Voltage-Gated Sodium Channel/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.1 Voltage-Gated Sodium Channel/antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.2 Voltage-Gated Sodium Channel/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.2 Voltage-Gated Sodium Channel/antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.3 Voltage-Gated Sodium Channel/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.3 Voltage-Gated Sodium Channel/antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.4 Voltage-Gated Sodium Channel/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.4 Voltage-Gated Sodium Channel/antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.5 Voltage-Gated Sodium Channel/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.5 Voltage-Gated Sodium Channel/antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.6 Voltage-Gated Sodium Channel/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.6 Voltage-Gated Sodium Channel/antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.7 Voltage-Gated Sodium Channel/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.7 Voltage-Gated Sodium Channel/antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.8 Voltage-Gated Sodium Channel/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.8 Voltage-Gated Sodium Channel/antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.9 Voltage-Gated Sodium Channel/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> NAV1.9 Voltage-Gated Sodium Channel/antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> Organofluorophosphonates/poisoning</td>
|
|
<td headers="a2"> Organophosphate Poisoning</td> </tr>
|
|
|
|
<tr><td headers="a1"> Organophosphates/poisoning</td>
|
|
<td headers="a2"> Organophosphate Poisoning</td> </tr>
|
|
|
|
<tr><td headers="a1"> Organophosphonates/poisoning</td>
|
|
<td headers="a2"> Organophosphate Poisoning</td> </tr>
|
|
|
|
<tr><td headers="a1"> Organophosphorus Compounds/poisoning</td>
|
|
<td headers="a2"> Organophosphate Poisoning</td> </tr>
|
|
|
|
<tr><td headers="a1"> Organothiophosphates/poisoning</td>
|
|
<td headers="a2"> Organophosphate Poisoning</td> </tr>
|
|
|
|
<tr><td headers="a1"> Organothiophosphonates/poisoning</td>
|
|
<td headers="a2"> Organophosphate Poisoning</td> </tr>
|
|
|
|
<tr><td headers="a1"> Oxalic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Oxalates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Oxaloacetic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Oxaloacetates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Plants/growth & development</td>
|
|
<td headers="a2"> Plant Development</td> </tr>
|
|
|
|
<tr><td headers="a1"> Proteasome Endopeptidase Complex/antagonists & inhibitors</td>
|
|
<td headers="a2"> Proteasome Inhibitors</td> </tr>
|
|
|
|
<tr><td headers="a1"> Receptors, Cannabinoid/agonists</td>
|
|
<td headers="a2"> Cannabinoid Receptor Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Receptors, Cannabinoid/antagonists & inhibitors</td>
|
|
<td headers="a2"> Cannabinoid Receptor Antagonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Receptors, Mineralocorticoid/antagonists & inhibitors</td>
|
|
<td headers="a2"> Mineralocorticoid Receptor Antagonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Research/methods</td>
|
|
<td headers="a2"> Research Design</td> </tr>
|
|
|
|
<tr><td headers="a1"> Salicylic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Salicylates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Skin/surgery</td>
|
|
<td headers="a2"> Dermatologic Surgical Procedures</td> </tr>
|
|
|
|
<tr><td headers="a1"> Sodium Channels/agonists</td>
|
|
<td headers="a2"> Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Succinic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Succinates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Tissues/transplantation</td>
|
|
<td headers="a2"> Tissue Transplantation</td> </tr>
|
|
|
|
<tr><td headers="a1"> Trichloroacetic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Chloroacetates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Trifluoroacetic Acid/analogs & derivatives</td>
|
|
<td headers="a2"> Fluoroacetates</td> </tr>
|
|
|
|
<tr><td headers="a1"> Visually Impaired Persons/education</td>
|
|
<td headers="a2"> Education of Visually Disabled</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channel beta Subunits/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channel beta Subunits/<br />
|
|
antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channel beta-1 Subunit/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channel beta-1 Subunit/<br />
|
|
antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channel beta-2 Subunit/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channel beta-2 Subunit/<br />
|
|
antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channel beta-3 Subunit/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channel beta-3 Subunit/<br />
|
|
antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channel beta-4 Subunit/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channel beta-4 Subunit/<br />
|
|
antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channels/agonists</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Agonists</td> </tr>
|
|
|
|
<tr><td headers="a1"> Voltage-Gated Sodium Channels/antagonists & inhibitors</td>
|
|
<td headers="a2"> Voltage-Gated Sodium Channel Blockers</td> </tr>
|
|
|
|
</tbody>
|
|
</table>
|
|
</div>
|
|
<p class="articleParagraph">
|
|
|
|
|
|
|
|
|
|
</p>
|
|
</div>
|
|
<div class="footer">
|
|
<p class="footerLeft"><span class="footerissn"><strong>ISSN 2161-2986 (Online)</strong> Content not copyrighted; freely reproducible.</span><br/>
|
|
<a href="/">National Library of Medicine</a> 8600 Rockville Pike, Bethesda, MD 20894
|
|
<br/>
|
|
<a href="//www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a>,
|
|
<a href="//www.nlm.nih.gov/web_policies.html">Web Policies</a>,
|
|
<a href="//www.nlm.nih.gov/careers/jobopenings.html">Careers</a>,
|
|
<a href="//www.nlm.nih.gov/accessibility.html">Accessibility</a>,
|
|
<a href="//www.usa.gov/" id="anch_34">USA.gov</a>,
|
|
<a href="//www.hhs.gov/vulnerability-disclosure-policy/index.html">HHS Vulnerability Disclosure</a>
|
|
<br/>
|
|
|
|
<a href="//www.nih.gov/">NIH</a>,
|
|
<a href="https://www.hhs.gov/">HHS</a>,
|
|
<a href="//www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office">FOIA</a>,
|
|
<a class="supportLink" href="//support.nlm.nih.gov?from=" target="_blank">NLM Support Center</a>
|
|
|
|
</p>
|
|
|
|
<p class="footerRight">
|
|
<strong>Last updated:</strong> 18 July 2013</p>
|
|
</div>
|
|
</div>
|
|
<map id="nlm_masthead_113" name="nlm_masthead_113">
|
|
<area shape="rect" alt="NLM Technical Bulletin" coords="1,15,396,45" href="//www.nlm.nih.gov/pubs/techbull/tb.html" title="NLM Technical Bulletin" />
|
|
<area shape="rect" alt="National Library of Medicine" coords="0,47,203,62" href="//www.nlm.nih.gov/" title="National Library of Medicine" />
|
|
<area shape="rect" coords="207,47,396,62" href="//www.nih.gov/" alt="National Institutes of Health" title="" />
|
|
</map>
|
|
<!--*****************************Content end*******************************-->
|
|
<script src="/scripts/support.js"></script>
|
|
<script src="/core/nlm-notifyExternal/1.0/nlm-notifyExternal.min.js"></script>
|
|
</body>
|
|
</html>
|
|
|